Delivery Order SPE2DB20D3103-SPE2DB24FM6N6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,751.01 delivery order contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award is a $16,293.77 Firm Fixed Price delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The award has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $3,955.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a completion date of May 7, 2024 and is a firm fixed-price delivery order. This award is not set-aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award, valued at $1,999.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 and running through November 2026. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product used for diabetes management. The contract has no set-aside...
- This federal contract award, valued at $9,972.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to manage diabetes. The contract has a firm...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,421.42, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. This is a firm fixed-price delivery order contract with an ultimate completion date of August 16, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order worth $12,397.02 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to manage diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This federal contract award, valued at $12,591.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication used for the treatment of diabetes. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,305.43 firm fixed-price delivery order covers the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty diabetes medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $10,826.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM6N6Delivery Order
This federal contract award, valued at $1,451.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication used for diabetes management. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen has extensive experience supplying pharmaceutical products and medical supplies to federal agencies, including the DLA and Department of Justice, to support the healthcare needs of military personnel, veterans, and other government beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/12/24 |